IQVIA’s NTB Forecast methodology revolutionizes pharmaceutical forecasting by focusing on patient acquisition, enabling accurate, nimble, and actionable forecasts. This approach enhances decision-making in investment, resource allocation, sales force sizing, promotional activities, and market access tactics, supporting brand performance from launch through its lifecycle.
Key Takeaways:
Speakers:
Ester Oben Etah
Sr. Principal, U.S. Launch Excellence, IQVIA
Brian Lasky
Sr. Principal, U.S. Launch Excellence Lead, IQVIA
Elyse Munoz
Director Thought Leadership, IQVIA
Gain high value access and increase the profitability of your brands